Periodontal Diseases in Patients with Type 1 Diabetes Mellitus: Pathogenetic and Clinical Aspects
Abstract
INTRODUCTION: Periodontal diseases in patients with type 1 diabetes mellitus (T1DM) represent a multifactorial clinicopathogenetic problem, driven by disturbances in carbohydrate metabolism, immune response, and microcirculation. Despite advances in modern medicine, timely diagnosis and optimization of therapy for periodontal diseases in T1DM remain of high clinical and scientific significance.
Objective
To systematize current data on pathogenetic and clinical aspects underlying the bidirectional relationship between T1DM and periodontal diseases.
Materials And Methods
We analyzed scientific publications from the past 20 years in PubMed, Scopus, and Google Scholar using key terms: “type 1 diabetes mellitus”, “periodontal diseases in type 1 diabetes”, “periodontitis”, and “bidirectional relationship”. KEY
Findings
Current evidence confirms the presence of a bidirectional relationship between T1DM and periodontal diseases. Chronic hyperglycemia contributes to the development and progression of periodontitis through alterations in the oral microbiome, activation of the AGEs–RAGE signaling pathway, microvascular dysfunction, neutrophil impairment, and defective reparative processes. Conversely, chronic periodontal inflammation exacerbates systemic inflammation and is associated with worsened glycemic control. These findings highlight the multifactorial pathogenesis of periodontal diseases in T1DM and underscore the need for an interdisciplinary approach and early diagnosis.
Conclusion
Improvement of early diagnostic methods and implementation of interdisciplinary, personalized management strategies for patients with T1DM and periodontal diseases may enhance clinical outcomes. A promising direction is the development and validation of integrated clinical–laboratory algorithms for risk assessment and prognosis of dental complications in T1DM.